关注
Dora Visnjic
Dora Visnjic
Professor of Physiology and Immunology, University of Zagreb School of Medicine, Croatian Institute
在 mef.hr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
107192021
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency
D Visnjic, Z Kalajzic, DW Rowe, V Katavic, J Lorenzo, HL Aguila
Blood 103 (9), 3258-3264, 2004
9872004
Col1a1‐driven transgenic markers of osteoblast lineage progression
S Dacic, I Kalajzic, D Visnjic, AC Lichtler, DW Rowe
Journal of bone and mineral research 16 (7), 1228-1236, 2001
1772001
Conditional ablation of the osteoblast lineage in Col2. 3Δtk transgenic mice
D Visnjic, I Kalajzic, G Gronowicz, HL Aguila, SH Clark, AC Lichtler, ...
Journal of bone and mineral research 16 (12), 2222-2231, 2001
1482001
Imunološke laboratorijske metode
I Andreis, D Višnjić
932004
AICAr, a widely used AMPK activator with important AMPK-independent effects: a systematic review
D Višnjić, H Lalić, V Dembitz, B Tomić, T Smoljo
Cells 10 (5), 1095, 2021
782021
Arachidonic Acid Mediates Interferon-γ–Induced Sphingomyelin Hydrolysis and Monocytic Marker Expression in HL-60 Cell Line
D Višnjić, D Batinić, H Banfić
Blood, The Journal of the American Society of Hematology 89 (1), 81-91, 1997
721997
The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells
K Matkovic, F Brugnoli, V Bertagnolo, H Banfic, D Visnjic
Leukemia 20 (6), 941-951, 2006
652006
Nuclear phosphoinositide 3-kinase C2β activation during G2/M phase of the cell cycle in HL-60 cells
D Višnjić, J Ćurić, V Crljen, D Batinić, S Volinia, H Banfić
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2003
532003
The activation of nuclear phosphoinositide 3-kinase C2β in all-trans-retinoic acid-differentiated HL-60 cells
D Višnjić, V Crljen, J Ćurić, D Batinić, S Volinia, H Banfić
FEBS letters 529 (2-3), 268-274, 2002
512002
Nuclear phospholipase C-beta1b activation during G2/M and late G1 phase in nocodazole-synchronized HL-60 cells.
V Lukinovic-Skudar, D Lana, D Banfíc, Hrvoje, Visnjic
Biochim Biophys Acta 1733 (2-3), 148-156, 2005
392005
Nuclear phospholipid signaling: phosphatidylinositol-specific phospholipase C and phosphoinositide 3-kinase
D Visnjic, H Banfic
Pflügers Archiv-European Journal of Physiology 455, 19-30, 2007
362007
Presence of different phospholipase C isoforms in the nucleus and their activation during compensatory liver growth
V Crljen, D Višnjić, H Banfić
FEBS letters 571 (1-3), 35-42, 2004
292004
Combined inhibition of PI3K and mTOR exerts synergistic antiproliferative effect, but diminishes differentiative properties of rapamycin in acute myeloid leukemia cells
J Mise, V Dembitz, H Banfic, D Visnjic
Pathology & Oncology Research 17, 645-656, 2011
282011
The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion
V Dembitz, B Tomic, I Kodvanj, JA Simon, A Bedalov, D Visnjic
Journal of Biological Chemistry 294 (42), 15257-15270, 2019
242019
Inositol pyrophosphates modulate S phase progression after pheromone-induced arrest in Saccharomyces cerevisiae
H Banfic, A Bedalov, JD York, D Visnjic
Journal of Biological Chemistry 288 (3), 1717-1725, 2013
242013
Epidermal growth factor stimulates translocation of the class II phosphoinositide 3-kinase PI3K-C2β to the nucleus
H Banfic, D Visnjic, N Mise, S Balakrishnan, S Deplano, YE Korchev, ...
Biochemical Journal 422 (1), 53-60, 2009
242009
5-Aminoimidazole-4-carboxamide ribonucleoside induces differentiation of acute myeloid leukemia cells
H Lalic, V Dembitz, V Lukinovic-Skudar, H Banfic, D Visnjic
Leukemia & lymphoma 55 (10), 2375-2383, 2014
232014
Bendamustine: A review of pharmacology, clinical use and immunological effects
H Lalic, I Aurer, D Batinic, D Visnjic, T Smoljo, A Babic
Oncology reports 47 (6), 1-16, 2022
212022
Different roles of protein kinase C α and δ isoforms in the regulation of neutral sphingomyelinase activity in HL-60 cells
D VIŠNJIĆ, D BATINIŠ, H BANFIŠ
Biochemical Journal 344 (3), 921-928, 1999
211999
系统目前无法执行此操作,请稍后再试。
文章 1–20